D
Avid Bioservices, Inc. CDMO
NASDAQ
Recommendation
Sell
Prev Close
$12.49
Volume
--
Avg Vol (90D)
1,678,841
Market Cap
$798.90M
Dividend & Yield
--
52-Week Range
$5.90 - $12.51
P/E (TTM)
--
EPS (TTM)
-$2.40
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
2/10/2025 - Globe Newswire
Avid Bioservices (NASDAQ:CDMO) Reaches New 12-Month High - Still a Buy?
2/7/2025 - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - Here's What Happened
2/5/2025 - MarketBeat
Avid Bioservices Acquired by GHO and Ampersand Capital
2/5/2025 - TipRanks Financial Blog
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change ...
2/5/2025 - GuruFocus
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
2/5/2025 - Globe Newswire
GHO Capital, Ampersand Capital announce closing of Avid Bioservices acquisition
2/5/2025 - TipRanks Financial Blog
GHO Capital, Ampersand Capital announce closing of Avid Bioservices acquisition
2/5/2025 - The Fly
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
2/5/2025 - Globe Newswire
Tokio Marine Asset Management Co. Ltd. Takes $7.32 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO)
2/2/2025 - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Sets New 1-Year High - Should You Buy?
2/1/2025 - MarketBeat
Double Digit IRR Likely With Avid Bioservices
2/1/2025 - SeekingAlpha
Avid Bioservices' stockholders approve transaction with GHO and Ampersand
1/30/2025 - The Fly
Avid Stockholders Approve Transaction with GHO and Ampersand
1/30/2025 - Globe Newswire
McGuire Investment Group LLC Has $145,000 Position in Avid Bioservices, Inc. (NASDAQ:CDMO)
1/25/2025 - MarketBeat
JPMorgan Chase & Co. Purchases 80,308 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
1/25/2025 - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Share Price Passes Above 200-Day Moving Average - Here's Why
1/23/2025 - MarketBeat
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
1/22/2025 - Globe Newswire
Avid Bioservices says ISS, Glass Lewis recommend vote 'FOR' transaction
1/21/2025 - The Fly
Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand
1/21/2025 - Globe Newswire
Proxy adviser ISS said to recommend Avid Bioservices holders vote for takeover
1/17/2025 - Seeking Alpha - Healthcare
Avid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - Should You Buy?
1/15/2025 - MarketBeat
Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Richard A. Richieri Sells 2,283 Shares of Stock
1/14/2025 - MarketBeat
Insider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,283 Shares of Stock
1/14/2025 - MarketBeat
Barclays PLC Acquires 66,653 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
1/13/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$150.45M
EBITDA (TTM)
-$7.91M
EBIT (TTM)
-$20.38M
Net Income (TTM)
-$152.05M
Balance Sheet
Total Assets (Q)
$323.48M
Total Debt (Q)
$207.02M
Total Liabilities (Q)
$278.67M
Book Value Per Share (Q)
$0.7006
Cash Flow
Cash from Operations (TTM)
$5.26M
Cash from Investing (TTM)
-$14.94M
Cash from Financing (TTM)
$11.67M
Net Change in Cash (TTM)
$1.99M
Filings
Filing Date
Tuesday, December 10, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
1.59
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Mar 07, 2024 - $5.90
52-week High
Feb 04, 2025 - $12.51
Valuation
Market Cap
$798.90M - Small Cap
Enterprise Value
$970.81M
Price/Sales (TTM)
5.30
Price/Book (Q)
17.83
Dividends and Shares
Shares Outstanding
63.84M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.avidbio.com
Phone Number
714 508 6100
Address
14191 Myford Road
Tustin, CA 92780
Country
United States
Year Founded
1981
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process... more
Weiss Ratings